Parkinson’s UK plans cruel experiments on monkeys
Parkinson’s UK, through ‘Virtual Biotech’, their drug development arm, will provide funding of more than £780,000 for work which will include testing a drug named NLX-112 on primates. The work will be in partnership with a drug company – Neurolixis – and with King’s College London, which has a colony of marmoset monkeys. Parkinson’s UK stated on their website that the work would include ‘safety and efficacy testing in a marmoset model of Parkinson’s’.
Although there are no details of exactly what the monkeys... Continued